Aprea Therapeutics, Inc. (NASDAQ:APRE) Short Interest Up 28.0% in March
Aprea Therapeutics, Inc. (NASDAQ:APRE – Get Free Report) was the recipient of a significant growth in short interest in the month of March. As of March 15th, there was short interest totalling 55,700 shares, a growth of 28.0% from the February 28th total of 43,500 shares. Based on an average daily trading volume, of 28,800 […]
